Yahoo Web Search

  1. Mallinckrodt plc MNK is scheduled to report third-quarter 2019 results on Nov 5, before market open. Mallinckrodt has surpassed expectations in the last four quarters, the ...

  2. NASDAQ: AMGN) AstraZeneca plc (NYSE: AZN) Bristol-Myers Squibb Co (NYSE: BMY)( reported better-than-expected third-quarter results) Celgene Corporation (NASDAQ: CELG)(third-quarter earnings ...

  3. Mallinckrodt: 3Q Earnings Snapshot

    Associated Press via Yahoo FinanceNov 05 11:24 AM

    Mallinckrodt PLC (MNK) on Tuesday reported a third-quarter loss of $1.1 million, after reporting a profit in the same period a year earlier. The Surrey, Britain-based company said ...

  4. Mallinckrodt receives SEC subpoena over Acthar gel lawsuit

    Reuters via Yahoo FinanceNov 05 23:23 PM

    Mallinckrodt Plc said on Tuesday it has received a subpoena from the U.S. Securities and Exchange Commission for documents related to the drugmaker's lawsuit against the U.S. Department ...

  5. NASDAQ: CLDX) – Phase 1 data for CDX-1140 in solid tumors (Friday, Nov. 8). Pieris Pharmaceuticals Inc (NASDAQ: PIRS) – Phase 1/2 data for PRS-343 in HER2-positive solid tumors. CELYAD SA/ADR ...

  6. (NASDAQ: CABA) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) Frequency Therapeutics Inc (NASDAQ: FREQ) Horizon Therapeutics PLC (NASDAQ: HZNP) Karyopharm Therapeutics Inc (NASDAQ: KPTI ...

  7. Mylan (MYL) to Report Q3 Earnings: What's in the Offing?

    Zacks via Yahoo FinanceOct 30 15:46 PM

    Mylan N.V. MYL is scheduled to report third-quarter 2019 results on Nov 5, before market open. Why a Likely Earnings Beat? Our proven model predicts an earnings beat for Mylan this season. The ...

  8. Mallinckrodt PLC (NYSE: MNK): already-released Phase 3 data for terlipressin in hepatorenal syndrome Type 1 (Monday). VBI Vaccines Inc (NASDAQ: VBIV): already-released Phase 3.

  9. Two charities will pay $6 million to resolve claims they operated as pass-throughs for seven pharmaceutical companies to pay kickbacks to Medicare patients using their high-priced medications ...

  10. Two charities will pay $6 million to resolve claims they operated as pass-throughs for seven pharmaceutical companies to pay kickbacks to Medicare patients using their high-priced medications ...